3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Neoplasms
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breath Test
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Sorafenib
20
lenvatinib
18
Hepatectomy
17
Blood Specimen Collection
12
Immune Checkpoint Inhibitors
11
atezolizumab
9
Liver Transplantation
9
Surgical Procedures, Operative
7
Radiofrequency Ablation
7
Observation
7
Bevacizumab
7
regorafenib
5
gadolinium ethoxybenzyl DTPA
5
sintilimab
4
donafenib
4
camrelizumab
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
tislelizumab
3
spartalizumab
3
Polymerase Chain Reaction
3
Neoadjuvant Therapy
3
Mass Spectrometry
3
Immunohistochemistry
3
Doxorubicin
3
Angiogenesis Inhibitors
3
toripalimab
2
pembrolizumab
2
entecavir
2
apatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Hepatocellular
×
Breath Tests
×
Clear all
NCT04620538
2026-03-30
VOCAL
Imperial College London
Completed
56 enrolled